These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 842209)

  • 1. [Possibility of indirect assessment of the reactogenicity of chemically sorbed typhoid-paratyphoid vaccines by the Shwartzman phenomenon].
    Luk'ianova EG; Andrievskaia RA
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):45-51. PubMed ID: 842209
    [No Abstract]   [Full Text] [Related]  

  • 2. The sensitizing effect of various typhoid vaccines as revealed under experimental conditions.
    Melikova EN; Lesnjak SV
    Bull World Health Organ; 1969; 40(3):395-9. PubMed ID: 5306623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Model of acute appendicitis reproduced by using the Shwartzman phenomenon].
    Fomin AN
    Patol Fiziol Eksp Ter; 1985; (1):59-61. PubMed ID: 3885145
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of the hyperergic inflammation reaction model (Schwartzman phenomenon) as a laboratory method of assessing the reactogenicity of typhoid vaccine].
    Aleksandrova TN
    Zh Mikrobiol Epidemiol Immunobiol; 1968 Feb; 45(2):93-101. PubMed ID: 5650726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccine therapy of typhoid and the Sanarelli-Shwartzman phenomenon].
    GEKS FJ
    Klin Wochenschr; 1950 May; 28(19-20):335-7. PubMed ID: 15437793
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaphylactoid (Sanarelli-Shwartzman) reaction following therapeutic antityphoid injections.
    LOVE J; DRISCOLL RH
    U S Nav Med Bull; 1945 Dec; 45():1104-10. PubMed ID: 21004219
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the toxicity and immunogenicity of antityphoid vaccines].
    Binsztein N; Cetrangolo R; Eiguer T
    Medicina (B Aires); 1972; 32(5):453-62. PubMed ID: 4649556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Should typhoid-paratyphoid vaccination be continued?].
    Mercier P; Antoine HM
    Bull Acad Natl Med; 1979 May; 163(5):446-50; discussion 450-1. PubMed ID: 15648337
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemorrhagic skin reactions (Schwartzman phenomenon) caused by Shiga and Typhus toxin].
    HEINLEIN H
    Klin Wochenschr; 1948 Feb; 26(5-6):87. PubMed ID: 18914716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improvement of dry heated sorbed typhoid vaccine].
    Morogova VM; Razumova ZV; Shtriter VA; Khokhlova NA; Urmancheeva ZI
    Zh Mikrobiol Epidemiol Immunobiol; 1970 Nov; 47(11):65-7. PubMed ID: 5505311
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of paratyphoid B vaccines with known reactogenicity by means of laboratory tests].
    Levina LA; Ozeretskovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):47-52. PubMed ID: 4979161
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled field trial with dried sorbed paratyphoid B and typhoid vaccines.
    Hejfec LB; Levina LA; Kuz'minova ML; Slavina AM; Levites NE; Abidov AZ; Goncarova LF
    Bull World Health Organ; 1971; 45(6):787-94. PubMed ID: 5004428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the effectiveness of 'standard' and 'AFIP' typhoid vaccines.
    Burney MI; Ahmed A; Karamat KA
    J Pak Med Assoc; 1980 Mar; 30(3):66-8. PubMed ID: 6770126
    [No Abstract]   [Full Text] [Related]  

  • 14. [Search for a laboratory model for evaluating the reactogenicity of typhoid vaccines. I. Development of a laboratory model of evaluating the reactive properties of typhoid vaccines in mice sensitized with pertussis vaccine].
    Lesniak SV
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Sep; 49(9):17-22. PubMed ID: 4653084
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reactogenicity and immunological effectiveness of a chemical sorbed typhoid vaccine in combination with choleragen-anatoxin administered subcutaneously by jet injector].
    Gapochko KG; Emel'ianova OV; Konovalov SI; Mokrousov VB; Ttiova TS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):95-7. PubMed ID: 6711201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trial of the new chemical sorbed typhoid monovaccine P in a strictly controlled experiment].
    Karpukhin GI; Andrievskaia RA; Shapiro NI; Luk'ianova EG; Belaia GN
    Zh Mikrobiol Epidemiol Immunobiol; 1976; (3):81-6. PubMed ID: 785908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of laboratory testing of the reactivity of various typhoid vaccines compared with the observation data in man].
    Melikova EN; Lesniak SV; Koval'skaia SIa
    Zh Mikrobiol Epidemiol Immunobiol; 1968; 45(10):119-24. PubMed ID: 5731556
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the epidemiological effectiveness of corpuscular and chemically sorbed typho-paratyphoid vaccines].
    KHEIFETS LB
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Jul; 33():53-9. PubMed ID: 14455611
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibility of the occurrence of the Shwartzman phenomenon during administration of a reacting dose of typhoid antigen through the respiratory tracts].
    Efremova VN
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Feb; (2):44-7. PubMed ID: 1124618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of typhoid fever vaccination].
    Mebel S; Rustenbach S
    Z Arztl Fortbild (Jena); 1973 Jan; 67(1):17-21. PubMed ID: 4580180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.